Scarica l'app Stockscreener
10.77
1.60%
0.17
Dopo l'orario di chiusura:
10.77
Precedente Chiudi:
$10.60
Aprire:
$10.62
Volume 24 ore:
927.95K
Relative Volume:
0.85
Capitalizzazione di mercato:
$1.05B
Reddito:
-
Utile/perdita netta:
$-137.25M
Rapporto P/E:
-5.6984
EPS:
-1.89
Flusso di cassa netto:
$-121.97M
1 W Prestazione:
+7.38%
1M Prestazione:
+10.52%
6M Prestazione:
+40.60%
1 anno Prestazione:
+12.30%
Intervallo 1D:
$10.31
$10.88
Intervallo di 1 settimana:
$9.87
$10.88
Portata 52W:
$3.8951
$14.67
Oric Pharmaceuticals Inc Stock (ORIC) Company Profile
Nome
Oric Pharmaceuticals Inc
Settore
Industria
Telefono
(650) 388-5600
Indirizzo
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
Confronta ORIC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORIC
Oric Pharmaceuticals Inc
|
10.77 | 1.01B | 0 | -137.25M | -121.97M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-08 | Iniziato | Ladenburg Thalmann | Buy |
| 2024-10-31 | Iniziato | Wells Fargo | Overweight |
| 2024-09-06 | Iniziato | Stifel | Buy |
| 2024-02-23 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-09-22 | Iniziato | Wedbush | Outperform |
| 2023-03-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-03-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-03-16 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2022-07-18 | Ripresa | Oppenheimer | Perform |
| 2022-04-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-03-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-03-22 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-22 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-03-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-07-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-01-25 | Downgrade | Citigroup | Buy → Neutral |
| 2020-08-13 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-08-03 | Iniziato | H.C. Wainwright | Buy |
| 2020-05-19 | Iniziato | Citigroup | Neutral |
| 2020-05-19 | Iniziato | Guggenheim | Buy |
| 2020-05-19 | Iniziato | JP Morgan | Overweight |
| 2020-05-19 | Iniziato | Jefferies | Buy |
Mostra tutto
Oric Pharmaceuticals Inc Borsa (ORIC) Ultime notizie
Combining machine learning predictions for ORIC Pharmaceuticals Inc.Bond Market & Real-Time Market Sentiment Alerts - Newser
Key metrics from ORIC Pharmaceuticals Inc.’s quarterly data2025 Historical Comparison & Entry Point Strategy Guides - Newser
ORIC Pharmaceuticals Inc. stock prediction for this weekMarket Trend Review & Free Technical Confirmation Trade Alerts - Newser
Will earnings trigger a reversal in ORIC Pharmaceuticals Inc.July 2025 Technicals & Community Trade Idea Sharing Platform - Newser
Detecting price anomalies in ORIC Pharmaceuticals Inc. with AIDip Buying & Technical Confirmation Trade Alerts - Newser
What momentum shifts mean for ORIC Pharmaceuticals Inc.Weekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
Real time pattern detection on ORIC Pharmaceuticals Inc. stock2025 Top Gainers & Verified Momentum Stock Alerts - Newser
Nuveen LLC Makes New Investment in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Using fundamentals and technicals on ORIC Pharmaceuticals Inc.2025 Major Catalysts & Pattern Based Trade Signal System - Newser
How to interpret RSI for ORIC Pharmaceuticals Inc. stockTrade Entry Report & Reliable Price Breakout Signals - Newser
Is ORIC Pharmaceuticals Inc. still worth holding after the dipPortfolio Growth Summary & Weekly Top Gainers Trade List - Newser
Is ORIC Pharmaceuticals Inc. forming a breakout pattern2025 Retail Activity & Safe Swing Trade Setup Alerts - khodrobank.com
Real time breakdown of ORIC Pharmaceuticals Inc. stock performancePortfolio Return Summary & Detailed Earnings Play Alerts - Newser
Is ORIC Pharmaceuticals Inc. a candidate for recovery playQuarterly Trade Review & Free Accurate Trade Setup Notifications - Newser
Is ORIC Pharmaceuticals Inc. forming a bullish divergenceJuly 2025 Trade Ideas & High Accuracy Swing Entry Alerts - khodrobank.com
Is ORIC Pharmaceuticals Inc. meeting your algorithmic filter criteriaDip Buying & Technical Confirmation Trade Alerts - Newser
ORIC Pharmaceuticals Inc. recovery potential after sell offTrade Analysis Summary & Weekly Stock Breakout Alerts - Newser
Is ORIC Pharmaceuticals Inc. stock bottoming outWeekly Earnings Recap & Real-Time Volume Trigger Notifications - Newser
Does ORIC Pharmaceuticals Inc. have pricing powerPortfolio Update Summary & Growth Oriented Trading Recommendations - khodrobank.com
DAFNA Capital Management LLC Invests $1.35 Million in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Using data tools to time your ORIC Pharmaceuticals Inc. exit2025 Performance Recap & Detailed Earnings Play Strategies - Newser
What MACD signals say about ORIC Pharmaceuticals Inc.Watch List & Target Return Focused Picks - Newser
Visualizing ORIC Pharmaceuticals Inc. stock with heatmapsJuly 2025 Momentum & Community Consensus Picks - Newser
Market reaction to ORIC Pharmaceuticals Inc.’s recent newsQuarterly Risk Review & Weekly Top Gainers Alerts - Newser
Custom watchlist performance reports with ORIC Pharmaceuticals Inc.Trend Reversal & Consistent Growth Stock Picks - Newser
Analysts Spot Bullish Divergence in ORIC Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Custom strategy builders for tracking ORIC Pharmaceuticals Inc.Portfolio Update Report & Weekly Setup with ROI Potential - Newser
Will ORIC Pharmaceuticals Inc. see short term momentumTrade Risk Assessment & Fast Moving Stock Trade Plans - Newser
Analysts Set Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) PT at $17.63 - MarketBeat
Signal strength of ORIC Pharmaceuticals Inc. stock in tech scannersQuarterly Performance Summary & Scalable Portfolio Growth Ideas - Newser
ORIC Pharmaceuticals Inc. stock trendline breakdownCPI Data & Capital Protection Trade Alerts - Newser
Will a bounce in ORIC Pharmaceuticals Inc. offer an exitRate Hike & Weekly High Conviction Ideas - Newser
Oric Pharmaceuticals Inc Azioni (ORIC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Oric Pharmaceuticals Inc Azioni (ORIC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic | Chief Financial Officer |
Jun 24 '25 |
Sale |
10.50 |
32,466 |
341,039 |
68,317 |
| Piscitelli Dominic | Chief Financial Officer |
Jun 23 '25 |
Sale |
10.00 |
1,034 |
10,344 |
100,783 |
| You Angie | Director |
Jun 20 '25 |
Buy |
9.39 |
26,597 |
249,669 |
26,597 |
| You Angie | Director |
Jun 23 '25 |
Buy |
9.43 |
1,403 |
13,230 |
28,000 |
| Piscitelli Dominic | Chief Financial Officer |
Jun 12 '25 |
Sale |
10.00 |
300 |
3,000 |
101,817 |
| Piscitelli Dominic | Chief Financial Officer |
Jun 11 '25 |
Sale |
10.01 |
2,976 |
29,777 |
102,117 |
| Piscitelli Dominic | Chief Financial Officer |
Jun 10 '25 |
Sale |
10.00 |
324 |
3,240 |
105,093 |
| Piscitelli Dominic | Chief Financial Officer |
Jun 06 '25 |
Sale |
10.01 |
2,600 |
26,021 |
104,164 |
| Piscitelli Dominic | Chief Financial Officer |
Jun 09 '25 |
Sale |
10.00 |
300 |
3,000 |
103,864 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):